Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Association of ALPL variants with serum alkaline phosphatase and bone traits in the general Japanese population: The Nagahama Study

Abstract

Although alkaline phosphatase (ALP) activity is relatively low in carriers of recessive type hypophosphatasia (HPP), most are asymptomatic and therefore do not undergo medical evaluations. We analyzed the association of ALP-encoding ALPL variants with serum ALP and bone traits in the general Japanese population. Study participants (n = 9671) were from the Nagahama Study, which was a longitudinal cohort study of an apparently healthy general Japanese population. ALPL variants were analyzed by whole-genome sequencing or TaqMan probe assays using DNA extracted from peripheral blood samples. The speed of sound in calcaneal bone was assessed by quantitative ultrasound (QUS) and used as surrogate measures of bone mineral density. We identified 13 ALPL variants. Minor allele frequencies of three variants were higher than expected. Variant c.529G > A has been reported as a possible pathogenic variant for adult type HPP. Variants c.979C > T and c.1559delT are reported as pathogenic variants for perinatal severe HPP or infantile HPP. The allele frequencies of c.529G > A, c.979C > T, and c.1559delT were 0.0107, 0.0040, and 0.0014, respectively. Serum ALP activity was significantly lower and differed among the three variants (P < 0.001), as well as between individuals with and without any of the three variants (P < 0.001). Serum ALP activity was inversely associated with QUS values, although no direct association was observed between the ALPL variants and QUS values. An association between serum ALP activity and QUS was confirmed; however, we failed to detect an association between ALPL variants and bone traits in the general Japanese population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Mornet E. Hypophosphatasia. Metabolism. 2018;82:142–55.

    Article  CAS  Google Scholar 

  2. Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011;75:439–45.

    Article  Google Scholar 

  3. Okazaki Y, Kitajima H, Mochizuki N, Kitaoka T, Michigami T, Ozono K. Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth. Eur J Pediatr. 2016;175:433–7.

    Article  CAS  Google Scholar 

  4. The Tissue Nonspecific Alkaline Phosphatase Gene Mutations Database. http://www.sesep.uvsq.fr/03_hypo_mutations.php [Accessed 30 Aug 2019].

  5. Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S. Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child. 2014;99:211–5.

    Article  Google Scholar 

  6. Watanabe A, Karasugi T, Sawai H, Naing BT, Ikegawa S, Orimo H, et al. Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers. J Hum Genet. 2011;56:166–8.

    Article  CAS  Google Scholar 

  7. Takahashi Y, Sawai H, Murotsuki J, Satoh S, Yamada T, Hayakawa H, et al. Parental serum alkaline phosphatase activity as an auxiliary tool for prenatal diagnosis of hypophosphatasia. Prenat Diagn. 2017;37:491–6.

    Article  CAS  Google Scholar 

  8. Hofmann C, Girschick H, Mornet E, Schneider D, Jakob F, Mentrup B. Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia. Eur J Hum Genet. 2014;22:1160–4.

    Article  CAS  Google Scholar 

  9. Michigami T, Uchihashi T, Suzuki A, Tachikawa K, Nakajima S, Ozono K. Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia. Eur J Pediatr. 2005;164:277–82.

    Article  CAS  Google Scholar 

  10. Gehring B, Mornet E, Plath H, Hansmann M, Bartmann P, Brenner RE. Perinatal hypophosphatasia: diagnosis and detection of heterozygote carriers within the family. Clin Genet. 1999;56:313–7.

    Article  CAS  Google Scholar 

  11. Spentchian M, Merrien Y, Herasse M, Dobbie Z, Gläser D, Holder SE, et al. Severe hypophosphatasia: characterization of fifteen novel mutations in the ALPL gene. Hum Mutat. 2003;22:105–6.

    Article  CAS  Google Scholar 

  12. Zankl A, Mornet E, Wong S. Specific ultrasonographic features of perinatal lethal hypophosphatasia. Am J Med Genet A. 2008;146A:1200–4.

    Article  Google Scholar 

  13. Sergi C, Mornet E, Troeger J, Voigtlaender T. Perinatal hypophosphatasia: radiology, pathology and molecular biology studies in a family harboring a splicing mutation (648+1A) and a novel missense mutation (N400S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene. Am J Med Genet. 2001;103:235–40.

    Article  CAS  Google Scholar 

  14. Tabara Y, Ikezoe T, Yamanaka M, Setoh K, Segawa H, Kawaguchi T, et al. Nagahama Study Group. Advanced glycation end product accumulation is associated with low skeletal muscle mass, weak muscle strength, and reduced bone density: the Nagahama study. J Gerontol A Biol Sci Med Sci. 2019. https://doi.org/10.1093/gerona/gly233.

    Article  Google Scholar 

  15. Setoh K, Terao C, Muro S, Kawaguchi T, Tabara Y, Takahashi M, et al. Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels. Nat Commun. 2015;6:7754.

    Article  CAS  Google Scholar 

  16. Hosoda Y, Yoshikawa M, Miyake M, Tabara Y, Ahn J, Woo SJ, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci USA. 2018;115:6261–6.

    Article  CAS  Google Scholar 

  17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.

    Article  CAS  Google Scholar 

  18. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491–8.

    Article  CAS  Google Scholar 

  19. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.

    Article  CAS  Google Scholar 

  20. Otani T, Fukunaga M, Yoh K, Miki T, Yamazaki K, Kishimoto H, et al. Attempt at standardization of bone quantitative ultrasound in Japan. J Med Ultrason. 2001;45:3–13. 2018.

    Article  Google Scholar 

  21. Morita R, Yamamoto I, Yuu I, et al. Quantitative ultrasound for the assessment of bone status. Osteoporos Int. 1997;7:S128–34.

    Article  Google Scholar 

  22. Nakano N, Eto A, Chikaura Y, Matsubara T, Koga K, Kawada K. Measurement of enzyme activity of control materials containing human enzymes by IFCC reference methods. Rinsho Byori. 1991;39:981–93. [in Japanese].

    PubMed  CAS  Google Scholar 

  23. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta. 1990;186:133–50.

    Article  CAS  Google Scholar 

  24. Yasuda J, Katsuoka F, Danjoh I, Kawai Y, Kojima K, Nagasaki M, et al. Regional genetic differences among Japanese populations and performance of genotype imputation using whole-genome reference panel of the Tohoku Medical Megabank Project. BMC Genomics. 2018;19:551.

    Article  CAS  Google Scholar 

  25. Orimo H, Goseki-Sone M, Hosoi T, Shimada T. Functional assay of the mutant tissue-nonspecific alkaline phosphatase gene using U2OS osteoblast-like cells. Mol Genet Metab. 2008;94:375–81.

    Article  CAS  Google Scholar 

  26. Nguyen HH, van de Laarschot DM, Verkerk AJMH, Milat F, Zillikens MC, Ebeling PR. Genetic risk factors for atypical femoral fractures (AFFs): a systematic review. JBMR. 2018;2:1–11.

    CAS  Google Scholar 

  27. Nielson CM, Zmuda JM, Carlos AS, Wagoner WJ, Larson EA, Orwoll ES, et al. Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density. J Bone Min Res. 2012;27:93–103.

    Article  CAS  Google Scholar 

  28. Flöter M, Bittar CK, Zabeu JL, Carneiro AC. Review of comparative studies between bone densitometry and quantitative ultrasound of the calcaneus in osteoporosis. Acta Reumatol Port. 2011;36:327–35.

    PubMed  Google Scholar 

  29. Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016;14:95–105.

    Article  Google Scholar 

  30. Ozono K, Yamagata M, Michigami T, Nakajima S, Sakai N, Cai G, et al. Identification of novel missense mutations (Phe310Leu and Gly439Arg) in a neonatal case of hypophosphatasia. J Clin Endocrinol Metab. 1996;81:4458–61.

    PubMed  CAS  Google Scholar 

  31. Komaru K, Ishida Y, Amaya Y, Goseki-Sone M, Orimo H, Oda K. Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded Secret Proteasomal Degrad FEBS J. 2005;272:1704–17.

    CAS  Google Scholar 

Download references

Acknowledgements

We are extremely grateful to the Nagahama City Office and the non-profit organization Zeroji Club for their assistance in analyzing the Nagahama Study. The Nagahama Study was supported by a University grant, the Center of Innovation Program, the Global University Project, and Grant-in-Aid for Scientific Research (25293141, 26670313, 26293198, 17H04182, 17H04126, 17H04123, and 18K18450) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Practical Research Project for Rare/Intractable Diseases (ek0109070, ek0109070, ek0109196, and ek0109348), the Comprehensive Research on Aging and Health Science Research Grants for Dementia R&D (dk0207006, dk0207027), the Program for an Integrated Database of Clinical and Genomic Information (kk0205008), the Practical Research Project for Lifestyle-related Diseases including Cardiovascular Diseases and Diabetes Mellitus (ek0210066, ek0210096, and ek0210116), and the Research Program for Health Behavior Modification by Utilizing IoT (le0110005) from Japan Agency for Medical Research and Development (AMED); the Takeda Medical Research Foundation; Mitsubishi Foundation; Daiwa Securities Health Foundation; and Sumitomo Foundation. This study was also supported by Research on Rare and Intractable Diseases, Health, Labor and Welfare Sciences Research Grants [H28-Nanchitou (Nan)-Ippan-017 and 19FC1006].

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yasuharu Tabara or Takahiro Yamada.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagata, M., Setoh, K., Takahashi, M. et al. Association of ALPL variants with serum alkaline phosphatase and bone traits in the general Japanese population: The Nagahama Study. J Hum Genet 65, 337–343 (2020). https://doi.org/10.1038/s10038-019-0712-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-019-0712-3

Search

Quick links